Role of BRCA1 and BRCA2 mutations in pancreatic cancer

Gut

Volumn 56, Issue 5, 2007, Pages 601-605

  Greer, Julia B ^a,b   Whitcomb, David C ^b  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; ESTROGEN;

BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CIGARETTE SMOKING; ESTROGEN BLOOD LEVEL; GENE INTERACTION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HIGH RISK POPULATION; HUMAN; OVARY CANCER; PANCREAS CANCER; PEDIGREE ANALYSIS; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

ESTROGENS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GERM-LINE MUTATION; HUMANS; MALE; PANCREATIC NEOPLASMS; PEDIGREE; SMOKING;

EID: 34247537444     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.101220     Document Type: Review

References (40)

1. Harris M, Winship I, Spriggs M. Controversies and ethical issues in cancer-genetics clinics. Lancet Oncol 2005;6:301-10.
2. Reimer RR, Fraumeni JF Jr, Ozols RF, et al. Pancreatic cancer in father and son. Lancet 1977;1:23.
3. Ghadirian P, Simard A, Baillargeon J. Cancer of the pancreas in two brothers and one sister. Int J Pancreatol 1987;2:383-91.
4. Ehrenthal D, Haeger L, Griffin T, et al. Familial pancreatic adenocarcinoma in three generations. A case report and a review of the literature. Cancer 1987;59:1661-4.
5. Lynch HT, Brand RE, Deters CA, et al. Hereditary pancreatic cancer. Pancreatology 2001;1:466-71.
6. Tersmette AC, Petersen GM, Offerhaus GJ, et al. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res 2001;7:738-44.
7. Hahn SA, Greenhalf B, Ellis I, et al. BRCA2 germline mutations in familial pancreatic carcinoma [see comment]. J Natl Cancer Inst 2003;95:214-21.
8. Lowenfels AB, Maisonneuve P. Epidemiologic and etiologic factors of pancreatic cancer. Hematol Oncol Clin N Am 2002;16:1-16.
9. Lynch HT, Deters CA, Snyder CL, et al. BRCA1 and pancreatic cancer: pedigree findings and their causal relationships. Cancer Genet Cytogenet 2005;158:119-25.
10. Thompson D, Easton D, Breast Cancer Linkage C. Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet 2001;68:410-19.
11. Thompson D, Easton DF, Breast Cancer Linkage C. Cancer incidence in BRCA1 mutation carriers [see comment]. J Natl Cancer Inst 2002;94:1358-65.
12. Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews [see comment]. N Engl J Med 1997;336:1401-8.
13. Thull DL, Vogel VG. Recognition and management of hereditary breast cancer syndromes. Oncologist 2004;9:13-24.
14. Knudson AG. Antioncogenes and human cancer. Proc Natl Acad Sci USA 1993;90:10914-21.
15. Prat J, Ribe A, Gallardo A. Hereditary ovarian cancer. Hum Pathol 2005;36:861-70.
16. Ghadirian P, Liu G, Gallinger S, et al. Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas. Int J Cancer 2002;97:807-10.
17. Ozcelik H, Schmocker B, Di Nicola N, et al. Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nat Genet 1997;16:17-18.
18. Robles-Diaz L, Goldfrank DJ, Kauff ND, et al. Hereditary ovarian cancer in Ashkenazi Jews. Familial Cancer 2004;3:259-64.
19. King MC, Marks JH, Mandell JB, et al. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 [see comment]. Science 2003;302:643-6.
20. Phelan CM, Lancaster JM, Tonin P, et al. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families [see comment][erratum appears in Nat Genet 1996;13:374]. Nat Genet 1996;13:120-2.
21. Brentnall TA. Cancer surveillance of patients from familial pancreatic cancer kindreds. Med Clin North Am 2000;84:707-18.
22. Murphy KM, Brune KA, Griffin C, et al. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. Cancer Res 2002;62:3789-93.
23. Chenevix-Trench G, Healey S, Lakhani S, et al. Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance. Cancer Res 2006;66:2019-27.
24. Thorlacius S, Olafsdottir G, Tryggvadottir L, et al. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenolypes [see comment]. Nat Genet 1996;13:117-19.
25. Schubert EL, Lee MK, Mefford HC, et al. BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2 [see comment]. Am J Hum Genet 1997;60:1031-40.
26. Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998;62:676-89.
27. Malone KE, Doling JR, Neal C, et al. Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases. Cancer 2000;88:1393-402.
28. Lubinski J, Phelan CM, Ghadirian P, et al. Cancer variation associated with the position of the mutation in the BRCA2 gene. Familial Cancer 2004;3:1-10.
29. Martin ST, Matsubayashi H, Rogers CD, et al. Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer. Oncogene 2005;24:3652-6.
30. Goggins M, Schutte M, Lu J, et al. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res 1996;56:5360-4.
31. Klein AP, Hruban RH, Brune KA, et al. Familial pancreatic cancer. Cancer J 2001;7:266-73.
32. Lowenfels AB, Maisonneuve P, Whitcomb DC, et al. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA 2001;286:169-70.
33. Schenk M, Schwartz AG, O'Neal E, et al. Familial risk of pancreatic cancer. J Natl Cancer Inst 2001;93:640-4.
34. Brunet JS, Ghadirian P, Rebbeck TR, et al. Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes [see comment]. J Natl Cancer Inst 1998;90:761-6.
35. Narod SA. Hormonal prevention of hereditary breast cancer. Ann N Y Acad Sci 2001;952:36-43.
36. Skinner HG, Michaud DS, Colditz GA, et al. Parity, reproductive factors, and the risk of pancreatic cancer in women. Cancer Epidemiol, Biomarkers Prev 2003;12:433-8.
37. Kreiger N, Lacroix J, Sloan M. Hormonal factors and pancreatic cancer in women. Ann Epidemiol 2001;11:563-7.
38. Duell EJ, Holly EA. Reproductive and menstrual risk factors for pancreatic cancer: a population-based study of San Francisco Bay Area women. Am J Epidemiol 2005;161:741-7.
39. Eisinger F. Breast cancer screening for women with a strong familial risk. Bull Cancer 2005;92:874-84.
40. Brand RE, Lynch HT. Identification of high-risk pancreatic cancer-prone families. Gastroenterol Clin N Am 2004;33:907-18.